secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2023-03-29T23:59:59+00:00
Accession:  0001213900-23-024177
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Vaccines enters ATM equity offering for up to $3.9M
--------------------------------------------------------------

- Entered ATM offering agreement with H.C. Wainwright to sell up to $3,900,000 of common stock.
- Agent commission fixed at 3.0% of gross proceeds from each sale.
- Shares sold at prevailing market prices on Nasdaq; no obligation to sell.
- Issued under existing S-3 registration statement effective March 16, 2023.
- Agreement may be terminated at any time by either party.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023024177/0001213900-23-024177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023024177/ea175921-8k_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-024177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer